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In this investigation the synthesis of diazenylthiazoles (3a-e) by the reaction of 
arylthiosemicarbazides with ω-bromoacetophenones via Eschenmoser-coupling reaction 
in acetonitrile and equimolar amounts of triethylamine and triphenylphosphine. Upon 
heating 1,4-disubstituted thiosemicarbazides with ω-bromoacetophenones in absolute 
ethanol, hydrazothiazoles (16a-i) were precipitated. On the other hand, the reaction of 
arylthiosemicarbazides with ω-bromoacetophenones in refluxing ethanol yielded 2-amino-
5-[4-aminophenyl]-4-phenylthiazolium bromide dihydrate derivatives (19a-g) via [5.5] 
sigmatropic shift The studied products were further characterized by IR, 1H NMR, 13C 
NMR and mass spectrometry. X-ray single crystal of 3a and 16h showed that, the 
molecules crystallized in the triclinic crystal system, space group P21/c. Whereas the X-
ray single crystal of 19b showed the molecule crystalized in orthorhombic, space group 
P212121. In the crystal of 19b, the lattice water and bromide ion associated through 
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1. Introduction 
The azo-dyes of heterocyclic compounds are useful structural components, due to their 
applications in textiles, papers, leather additives, foodstuffs, cosmetic industries and as 
organic solar cells and chemosensors [1-6]. Thiazole-azo dyes were synthesized during the 
reaction of thiourea with p-methoxyphenyl-ω-bromoacetophenone followed by coupling 
with N,N-diethylaniline [7], whereas 1,3-thiazolyl diazenyl-3-naphthalene derivatives have 
been synthesized by diazotization of 4-[4-ethylphenyl]thiazole-2-amine and coupling to N-
[4-chloro-2-methylphenyl]-3-hydroxynaphthalen-2-carboxamede [8]. Various derivatives 
of diazenyl-1,3-thiazoles were synthesized and their biological activities were evaluated 
[9,10].  
Recently, we reported that the reaction of hydrazinecarbothioamides with 
tetracyanoethylene (TCNE) gave azothiazoles [11]. Azo-benzothiazole chromophores 
possess large molecular hyperpolarizeability and showed that they are a good choice for 
nonlinear optics (NLO) materials [12,13]. 
 2-(3-(1H-Indol-3-yl)-5-(p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)-5-(aryldiazenyl)-4-thiazoles 
were synthesized from 3-(1H-indolyl)-5-(p-tolyl)-4,5-dihydropyrazole-1-carbothioamide 
and keto-hydrazonyl halides. The latter compounds have been evaluated for their 
antitumor activity against the MCF-7 human breast carcinoma cell line [14], also, 
indolylmethylidenehydrazinyl-4-aryl-5-(aryldiazenyl)-thiazoles also have been 
synthesized [15].                     
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2,4,5-Trisubstituted-1,3-thiazole derivatives including a hydrazide-hydrazone moiety have 
been synthesized and evaluated towards antitumor activity against some human cancer 
[16]. 
The reaction of ω-bromoacetophenones with ethylidene hydrazinecarbothioamides gave 
substituted ethylidene hydrazinylthiazoles which exhibited anti-bacterial activity [17]. (E)-
2-(2-(2-Nitrobenzylidene)thiazoles and (E)-3,4-diaryl-2-(cycloalkylidene-hyrazono)-
thiazoles were formed during the reaction of ω-bromoacetophenones with 2-(1-alkyl-
methylidene)hydrazinecarbothioamides and cycloalkylidene-N-phenylhydrazine-
carbothioamides [18]. 
4-Methyl-(1-benzyllidenehydrazinyl)-2-carbothioamide reacted with ethylbromopyruvate 
to give ethyl-2-(4-methyl-(2-benzylidenehydrazinyl)thiazole-4-carboxylates [19].  
Gomha et al. reported that, 1,4-bis(1-(5-aryldiazenyl)thiazol-2-yl)-3-(thiophen-2-yl)-4,5-
dihydro-1H-pyrazol-5-yl)benzene was formed during the reaction of 5,5`-(4,4-phenlene)-
bis-(3-thiophen-2-yl)-4,5-dihydro-pyrazole-1-carbothioamide with hydrazonyl halides 
[20]. 
Heterocyclization of 2-(1-alkylethylidene)hydrazinecarbothioamides afforded the 
formation of monohydrated pyridinium bromide-1,3-thiazolidenehydrazinylidene ethyl, 
1,3-thiazolylidenehydrazinium bromide and thiazolylidenehydrazines [21].  
Hydrazine derivatives are known to undergo rearrangements with N-H bond fission [22]. 
It has been reported, that the addition of benzophenonephenylhydrazone to polyphosphoric 
acid (PPA) under heating, o-phenylenediamine and benzophenone was observed [22]. 
A [5.5]sigmatropic shift of bis-thiazolylhydrazines in acidic catalyzed rearranged to p-
aminophenylthiazoles in addition to, bis(2-aminothiazoles) [23].  
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2. Experimental  
2.1.  Instrumentation 
Gallenkamp melting point apparatus was used to determine the melting points. IR 
spectra were recorded with Alpha, Bruker FT-IR instruments using potassium bromide 
pellets. NMR spectra were recorded for 1H NMR at 400 MHz and 13C NMR at 100 
MHz on a Bruker AM 400 spectrometry with TMS as internal standard (δ = 0), and 
data are reported as follows: Chemical shift, multiplicity (s = singlet, d = doublet, m = 
multiplet, br = broad). For 13C NMR, TMS (δ = 0) was used as internal standard and 
spectra were obtained with complete proton decoupling. Finnigan MAT instrument was 
used to record the mass spectra (70 eV, EI-mode). Elemental analyses for C, H, N, and 
S were carried out using an Elmyer 306. Preparative layer chromatography (plc) was 
carried out on glass plates covered with a 1.0 mm thick layer of slurry-applied silica gel 
(Merck Pf254). 
 
2.2.  Chemicals 
2.2.1. Starting materials  
Monosubstituted and disubstituted thiosemicarbazides were prepared according to 
literature methods (1a [23], 1b [24], 1c [11], 1d [25], 15a-d [26]). ω-Bromoacetophenone 
2a,b were prepared according to literature [27,28]. 
 
2.2.2. Synthesis of substituted diazenylthiazoles 3a-e. 
Equimolar amounts of thiosemicarbazides 1a-d (1a, 0.167; 1b, 0.201; 1c, 0.245 and 1d, 
0.257g) and ω-bromoacetophenone 2a/b (2a, 0.198; 2b, 0.277 g) were stirred in 20 ml dry 
CH3CN for 16 h at room temperature. The dried salt was redissolved in CH3CN, followed 
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by adding other equivalents of triethylamine and triphenylphosphine. The mixture was 
refluxed for 10-16 h, H2O (30 ml) was added and the resulting mixture was extracted with 
CH2Cl2. The organic extracts were dried over anhydrous CaCl2, filtered and concentrated. 
The residue was subjected to chromatographic plates (plc) using toluene/ethyl acetate 
(10:1) to give an orange main zone which was extracted with acetone to give compounds 
3a-e (Scheme 1). 
2.2.2.1. (E)-4-Phenyl-2-(phenyldiazenyl)thiazole (3a)  
Orange crystals (acetonitrile); yield 217 mg (82%); Mp. 158-159 °C; 1H NMR (400 MHz, 
CDCl3): δ 7.40-7.58 (m, 6H, Ar-H), 7.62 (s, 1H, thiazole-H), 8.03-8.88 (m, 4H, Ar-H) 
ppm; 13C NMR (100 MHz, CDCl3): δ 115.88 (thiazole-CH), 123.25, 125.62, 126.83, 
128.75, 129.53, 130.81 (Ar-CH), 133.91, 134.23, (Ar-C), 155.85 (thiazole-C4), 168.46 
(thiazole-C2) ppm; IR (KBr): ν = 3105 (Ar-CH), 1600 (C=N), 1585 (Ar-C=C), 1560, 1444 
cm-1 (N=N); MS (70 eV): m/z (%) = 265 (M+, 58), 189 (12), 160 (28), 105 (17), 77 (100); 
Anal. Calcd for C15H11N3S (265.33): C 67.90, H 4.18, N 15.84, S 12.08; Found: C 67.78, 
H 4.11, N 16.02, S 11.97. 
2.2.2.2. (E)-2-((3-Chlorophenyl)diazenyl))-4-phenylthiazole  
(3b) Pale orange crystals (acetonitrile); yield 248 mg (83%); Mp. 148-149°C; 1H NMR 
(400 MHz, CDCl3): δ 7.30-7.45 (m, 5H, Ar-H), 7.55 (s, 1H, thiazole-H), 7.85-7.88 (m, 1H, 
Ar-H), 7.92-8.00 (m, 3H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δ 116.69 (thiazole-
CH), 123.98, 124.00, 127.20, 129.68, 129.86, 131.27, 133.48 (Ar-CH), 134.60, 136.43, 
142.12 (Ar-C), 157.48 (thiazole-C4), 169.84 (thiazole-C2) ppm; IR (KBr): ν = 3080 (Ar-
CH), 1608 (C=N), 1592 (Ar-C=C), 1562, 1442 cm-1 (N=N); MS (70 eV): m/z (%) = 
301/299 (M+, 38), 223 (13), 189 (67), 160 (100), 141 (17), 113 (12); Anal. Calcd for 
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C15H10ClN3S (299.78): C, 60.10, H 3.36, Cl 11.83, N 14.02, S 10.70; Found: C 59.97, H 
3.45, Cl 11.77, N 13.91, S 10.82. 
2.2.2.3. (E)-4-Phenyl-2-(tosyldiazenyl)thiazole (3c)  
Orange crystals (acetonitrile); yield 274 mg (80%); Mp. 175-176°C; 1H NMR (400 MHz, 
CDCl3): δ 2.50 (s, 3H, CH3); 6.90-7.00 (m, 2H, Ar-H), 7.15-7.41 (m, 5H, Ar-H), 7.52 (s, 
1H, thiazole-H), 7.62-7.79 (m, 2H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δ 22.37 
(CH3), 116.75 (thiazole-CH), 123.77, 127.61, 128.54, 129.70, 130.12 (Ar-CH), 135.48, 
141.01, 142.86 (Ar-C), 156.67 (thiazole-C4), 168.55 (thiazole-C2) ppm; IR (KBr): ν = 
3085 (Ar-CH), 1605 (C=N), 1594 (Ar-C=C), 1568, 1450 cm-1 (N=N); MS (70 eV): m/z 
(%) = 343 (M+, 100), 265 (46), 189 (58), 184 (30), 160 (23), 155 (43), 91 (17), 77 (51); 
Anal. Calcd for C16H13N3O2S2 (343.42): C 55.96, H 3.82, N 12.24, S 18.67; Found: C 
56.12, H 3.91, N 12.15, S 18.58. 
2.2.2.4. (E)-2-((2,4-Dinitrophenyl)diazenyl))-4-phenylthiazole (3d)  
Orange crystals (acetonitrile); yield 287 mg (81%); Mp. 193-195 °C; 1H NMR (400 MHz, 
DMSO-d6): δ 7.35-7.43 (m, 6H, Ar-H), 7.55 (s, 1H, thiazole-H), 7.94-8.03 (m, 1H, Ar-H), 
8.30-8.40 (m, 1H, Ar-H) ppm, 13CNMR (100 MHz, DMSO-d6): δ 115.59 (thiazole-CH), 
121.73, 126.10, 128.48, 128.81, 129.16, 129.63 (Ar-CH), 133.49, 134.55, 140.12, 142.16 
(Ar-C), 157.11 (thiazole-C4), 169.69 (thiazole-C2) ppm; IR (KBr): ν = 3078 (Ar-CH), 
1612 (C=N), 1602 (Ar-C=C), 1558, 1448 cm-1 (N=N); MS (70 eV): m/z (%) = 355 (M+, 
100), 279 (38), 197 (53), 189 (71), 183 (80), 167 (28), 160 (56), 123 (22); Anal. Calcd for 




2.2.2.5. (E)-4-(4-Bromophenyl)-2-((2,4-dinitrophenyl)diazenyl)thiazole (3e)  
Orange crystals (acetonitrile); yield 373 mg (86%); Mp. 182-183°C; 1H NMR (400 MHz, 
DMSO-d6): δ 7.24-7.55 (m, 4H, Ar-H), 7.58 (s, 1H, thiazole-H), 7.81-7.86 (m, 1H, Ar-H), 
7.92-8.00 (m, 1H, Ar-H), 8.31-8.39 (m, 1H, Ar-H) ppm; 13C NMR (100 MHz, DMSO-d6): 
δ 114.34 (thiazole-CH), 121.32, 125.98, 128.03, 130.12, 131.87 (Ar-CH), 132.71, 134.16, 
138.73, 139.14, 141.82 (Ar-C), 156.35 (thiazole-C4), 167.91 (thiazole-C2) ppm; IR (KBr) 
ν: 3063 (Ar-CH), 1608 (C=N), 1596 (Ar-C=C), 1570, 1442 cm-1 (N=N); MS (70 eV): m/z 
(%) = 437/435 (M+, 63), 279 (14), 267 (100), 238 (81), 197 (53), 167 (27), 155 (62), 123 
(22); Anal. Calcd for C15H8BrN5O4S (434.22): C 41.49, H 1.86, Br 18.40, N 16.13, S 7.38; 
Found: C 41.61, H 1.72, Br 18.29, N 16.25, S 7.47. 
2.2.3. Synthesis of substituted hydrazono-2,3-dihydrothiazoles 16a-i 
A mixture of ω-bromoacetophenone 2a/b (1.0 mmol, 2a, 0.198; 2b, 0.277 g) and 1,4-
disubstituted thiosemicarbazides 15a-e (1.0 mmol, 15a, 0.333; 15b, 0.339; 15c, 0.285; 15 
d, 0.297 and 15e, 0.335 g) in 30 ml absolute ethanol was heated under reflux with stirring 
for 4-6 h, the reaction was followed up by TLC analysis. The precipitate was allowed to 
stand, filtered, washed with 5 ml ethanol, dried and recrystallized from the mentioned 
solvent to give hydrazothiazoles 16a-i (Scheme 4). 
2.2.3.1. (Z)-2-(2-(2,4-Dinitrophenyl)hydrazono)-3,4-diphenyl-2,3-dihydrothiazole 
(16a)  
Brown crystals (methanol); yield 390 mg (90%); Mp. 241-243°C; 1H NMR (400 MHz, 
DMSO-d6) δ 6.82 (s, 1H, thiazole-H), 7.12-7.50 (m, 10H, Ar-H), 7.96-8.08 (m, 1H, Ar-H), 




13C NMR (100 MHz, DMSO-d6): δ 116.15 (thiazole-CH), 124.17, 125.24, 
126.82, 128.34, 129.07, 130.00, 130.90, 131.87, 132.50, (Ar-CH), 132.84, 135.66, 136.59, 
140.85, 141.18 (Ar-C), 145.00 (thiazole-C4), 165.83 (thiazole-C2) ppm; IR (KBr): ν = 
3254 (hydrazo-NH), 3015 (Ar-CH), 1621 (C=N), 1578 cm-1 (Ar-C=C); MS (70 eV): m/z 
(%) = 433 (M+, 100), 357 (28), 251 (14), 167 (13), 137 (73), 123 (32); Anal. Calcd for 
C21H15N5O4S (433.44): C 58.19, H 3.49, N 16.16, S 7.40; Found: C 58.22, H 3.56, N 
16.02, S 7.29. 
2.2.3.2. (Z)-3-Cyclohexyl-2-(2-(2,4-dinitrophenyl)hydrazono)-4-phenyl-2,3-
dihydrothiazole (16b)  
Brown crystals (methanol); yield 386 mg (88%); Mp. 230-232°C; 1H NMR (400 MHz, 
DMSO-d6): δ 1.06-1.09 (m, 4H, cyclohexyl-CH2), 1.76-1.78 (m, 6H, cyclohexyl-CH2), 
3.72-3.74 (m, 1H, cyclohexyl-CH), 6.91 (s, 1H, thiazole-H), 7.48-7.52 (m, 6H, Ar-H), 
8.28-8.38 (m, 1H, Ar-H), 8.87-8.89 (m, 1H, Ar-H), 10.53 (br, s, 1H, NH, exchange with 
D2O) ppm; 
13C NMR (100 MHz, DMSO-d6): δ 24.68, 25.56, 27.78 (cyclohexyl-CH2), 
58.88 (cyclohexyl-CH), 115.45 (thiazole-CH), 123.48, 128.80, 128.94, 129.59, 130.16, 
131.15 (Ar-CH), 135.62, 137.18, 139.00, 141.53 (Ar-C), 144.90 (thiazole-C4), 164.40 
(thiazole-C2) ppm; IR (KBr): ν = 3263 (hydrazo-NH), 3007 (Ar-CH), 2927-2865 (Ali-
CH), 1613 (C=N), 1585 cm-1 (Ar-C=C) ppm; MS (70 eV): m/z (%) = 439 (M+, 16), 363 
(34), 357 (32), 257 (55), 168 (8), 156 (100), 137 (73), 123 (47); Anal. Calcd for 
C21H21N5O4S (439.49): C 57.39, H 4.82, N 15.94, S 7.30; Found: C 57.27, H 4.91, N 
16.08, S 7.44. 
2.2.3.3. (Z)-2-(2-(2,4-Dinitrophenyl)hydrazono)-3-ethyl-4-phenyl-2,3-
dihydrothiazole (16c)  
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Brown crystals (methanol); yield 335 mg (87%); Mp. 222-224°C; 1H NMR (400 MHz, 
CDCl3): δ 1.28 (t, 3H, CH3, J = 7.66), 3.52 (q, 2H, CH2, J = 7.66), 7.10 (s, 1H, thiazole-H), 
7.45-7.75 (m, 6H, Ar-H), 8.22-8.30 (m, 1H, Ar-H), 8.92-8.94 (m, 1H, Ar-H), 10.32 (br, s, 
1H, NH, exchange with D2O) ppm; 
13C NMR (100 MHz, CDCl3): δ 15.28 (CH3), 38.78 
(CH2), 115.20 (thiazole-CH), 123.23, 126.71, 128.78, 129.81, 130.40, 131.20 (Ar-CH), 
131.88, 134.96, 139.11, 141.32 (Ar-C), 145.61 (thiazole-C4), 164.86 (thiazole-C2) ppm; 
IR (KBr): ν = 3195 (hydrazo-NH), 3018 (Ar-CH), 2925-2860 (Ali-CH), 1611 (C=N), 1581 
cm-1 (Ar-C=C); MS (70 eV): m/z (%) = 385 (M+, 100), 307 (32), 285 (15), 204 (12), 183 
(38), 167 (13), 137 (73), 123 (29); Anal. Calcd for C17H15N5O4S (385.40): C 52.98, H 
3.92, N 18.17, S 8.32; Found: C 53.11, H 4.09, N 18.06, S 8.21. 
2.2.3.4. (Z)-4-(4-Bromophenyl)-2-(2-(2,4-dinitrophenyl)hydrazono)-3-phenyl-2,3-
dihydrothiazole (16d) 
Brown crystals (methanol); yield 430 mg (84%); Mp. 252-254°C; 1H NMR (400 MHz, 
DMSO-d6): δ 6.86 (s, 1H, thiazole-H), 7.09-7.50 (m, 9H, Ar-H), 7.90-8.00 (m, 1H, Ar-H), 
8.20-8.27 (m, 1H, Ar-H), 8.78-8.84 (m, 1H, Ar-H), 10.53 (br, s, 1H, NH, exchange with 
D2O) ppm; 
13C NMR (100 MHz, DMSO-d6): δ 115.60 (thiazole-CH), 122.20; 123.31, 
128.38, 128.56, 129.17, 129.41, 129.86, 130.12 (Ar-CH), 130.33, 131.33, 135.96, 136.79, 
139.22, 140.89 (Ar-C), 146.29 (thiazole-C4), 166.04 (thiazole-C2) ppm; IR (KBr): ν = 
3254 (hydrazo-NH), 3015 (Ar-CH), 1621 (C=N), 1578 cm-1 (Ar-C=C); MS (70 eV): m/z 
(%) = 513/511 (M+, 100), 357 (38), 329 (70), 267 (64), 181 (44), 167 (33), 135 (76), 123 
(25); Anal. Calcd for C21H14BrN5O4S (512.34): C 49.23, H 2.75, Br 15.60, N 13.67, S 




dihydrothiazole (16e)  
Brown crystals (methanol); yield 409 mg (86%); Mp. 229-231°C; 1H NMR (400 MHz, 
CDCl3): δ 4.30-4.45 (m, 2H, allyl-CH2N), 4.90-5.00 (m, 2H, allyl-CH2=), 5.76-5.86 (m, 
allyl-CH=), 6.85 (s, 1H, thiazole-H), 7.41-7.45 (m, 2H, Ar-H), 7.69-7.73 (m, 2H, Ar-H), 
7.76-7.79 (m, 1H, Ar-H), 8.25-8.29 (m, 1H, Ar-H), 8.82-8.92 (m, 1H, Ar-H), 10.58 (br, s, 
1H, NH, exchange with D2O) ppm; 
13C NMR (100 MHz, CDCl3): δ 47.68 (allyl-CH2N), 
115.73 (thiazole-CH), 117.18 (allyl-CH2=), 124.80, 128.65, 129.87, 130.47, 133.57 (Ar-
CH), 134.28 (allyl-CH=), 135.96, 136.88, 138.11, 141.51, 142.92 (Ar-C), 145.15 
(thiazole-C4), 165.36 (thiazole-C2) ppm; IR (KBr): ν = 3193 (hydrazo-NH), 3014 (Ar-
CH), 1626 (C=N), 1602 cm-1 (Ar-C=C); MS (70 eV): m/z (%) = 477/475 (M+, 100), 435 
(29), 321 (61), 293 (15), 183 (12), 167 (64), 136 (71), 123 (54); Anal. Calcd for 
C18H14BrN5O4S (476.30): C 45.39, H 2.96, Br 16.78, N 14.70, S 6.73; Found: C 45.51, H 
3.06, Br 16.69, N 14.81, S 6.61. 
2.2.3.6. (Z)-3-Allyl-2-(2-(2,4-dinitrophenyl)hydrazono)-4-phenyl-2,3-dihydro-
thiazole (16f)  
Brown crystals (methanol); yield 353 mg (89%); Mp. 235-237°C; 1H NMR (400 MHz, 
CDCl3): δ 4.30-4.34 (m, 2H, allyl-CH2N), 5.11-5.20 (m, 2H, allyl-CH2=), 5.75-5.88 (m, 
allyl-CH=), 7.12 (s, 1H, thiazole-H), 7.22-7.32 (m, 3H, Ar-H), 7.43-7.48 (m, 2H, Ar-H), 
7.50-7.61 (m, 1H, Ar-H), 8.10-8.13 (m, 1H, Ar-H), 9.00-9.02 (m, 1H, Ar-H), 10.31 (br, s, 
1H, NH, exchange with D2O) ppm; 
13C NMR (100 MHz, CDCl3): δ 46.95 (allyl-CH2N), 
116.76 (thiazole-C5), 118.38 (allyl-CH2=), 124.42, 129.48, 130.65, 132.85, 132.94, 133.04 
(Ar-CH), 134.53 (allyl-CH=), 134.72, 137.25, 138.12, 143.16 (Ar-C), 145.82 (thiazole-
C4), 164.98 (thiazole-C2) ppm; IR (KBr): ν = 3223 (hydrazo-NH), 3018 (Ar-CH), 3018 
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(Ar-CH), 2975, 2852 (Ali-CH), 1619 (C=N), 1584 cm-1 (Ar-C=C); MS (70 eV): m/z (%) = 
397 (M+, 100), 321 (58), 215 (23), 183 (23), 136 (84), 123 (65); Anal. Calcd for 
C18H15N5O4S (397.41): C 54.40, H 3.80, N 17.62, S 8.07; Found: C 54.29, H 3.87, N 
17.78, S 7.91. 
2.2.3.7. (Z)-4-(4-Bromophenyl)-2-(2-(2,4-dinitrophenyl)hydrazono)-3-ethyl-2,3-
dihydrothiazole (16g)  
Brown crystals (methanol); yield 413 mg (89%); Mp. 227-228°C; 1H NMR (400 MHz, 
CDCl3): δ 1.22 (t, 3H, CH3, J = 7.77), 3.84 (q, 2H, CH2, J = 7.77), 7.06 (s, 1H, thiazole-
H), 7.25-7.32 (m, 2H, Ar-H), 7.42-7.65 (m, 2H, Ar-H), 7.85-7.92 (m, 1H, Ar-H), 8.35-
8.42 (m, 1H, Ar-H), 8.80-8.94 (m, 1H, Ar-H), 10.30 (br, s, 1H, NH, exchange with D2O) 
ppm; 13C NMR (100 MHz, CDCl3): δ 15.37 (CH3), 39.56 (CH2), 116.60 (thiazole-C5), 
123.77, 125.54, 128.40, 129.60, 130.87 (Ar-CH), 131.25, 134.62, 136.51, 139.34, 141.32 
(Ar-C), 145.90 (thiazole-C4), 164.48 (thiazole-C2) ppm; IR (KBr): ν = 3195 (hydrazo-
NH), 3018 (Ar-CH), 2925-2860 (Ali-CH), 1611 (C=N), 1581 cm-1 (Ar-C=C); MS (70 eV): 
m/z (%) = 465/463 (M+, 100), 308 (45), 283 (56), 204 (41), 183 (22), 176 (32), 167 (14), 
156 (51), 136 (67), 123 (22); Anal. Calcd for C17H14BrN5O4S (464.29): C 43.98, H 3.04, 
Br 17.21, N 15.08, S 6.91; Found: C 43.85, H 2.97, Br 17.09, N 14.96, S 6.87. 
2.2.3.8. (Z)-N'-(3-Benzyl-4-phenylthiazol-2(3H)-ylidene)-4-methylbenzenesulfono-
hydrazide (16h)  
Violet crystals (methanol); yield 357 mg (82%); Mp. 212-214 °C; 1H NMR (400 MHz, 
CDCl3): δ 2.30 (s, 3H, CH3), 4.82 (s, 2H, CH2Ph), 6.75 (s, 1H, thiazole-H), 6.92-7.42 (m, 
15H, Ar-H and NH, exchange with D2O) ppm; 
13C NMR (100 MHz, CDCl3): δ 21.60 
(CH3), 46.25 (CH2Ph), 115.76 (thiazole-C5), 125.87, 126.52, 127.62, 128.32, 128.60, 
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128.74, 129.05, 129.23 (Ar-CH), 132.71, 133.66, 135.20, 139.00 (Ar-C), 146.86 (thiazole-
C4), 163.45 (thiazole-C2) ppm; IR (KBr): ν = 3150 (hydrazo-NH), 3038 (Ar-CH), 2973 
(Ali-CH), 1614 (C=N), 1553 and 1491 cm-1 (Ar-C=C); MS (70 eV): m/z (%) = 435 (M+, 
100), 358 (52), 264 (36), 188 (25), 170 (87), 155 (54), 91 (73), 77 (60); Anal. Calcd for 
C23H21N3O2S2 (435.56): C 63.42, H 4.86, N 9.65, S 14.72; Found: C 63.34, H 4.76, N 
9.55, S 14.57. 
2.2.3.9. (Z)-3-Benzyl-2-(2-(2,4-dinitrophenyl)hydrazono)-4-phenyl-2,3-
dihydrothiazole (16i)  
Brown crystals (methanol); yield 402 mg (90%); Mp. 226-228 °C; 1H NMR (400 MHz, 
DMSO-d6): δ 5.08 (s, 1H, CH2Ph), 6.98 (s, 1H, thiazole-H), 7.05-7.50 (m, 11H, Ar-H), 
8.04-8.13 (m, 1H, Ar-H), 8.79-8.82 (m, 1H, Ar-H), 10.60 (br, s, 1H, NH, exchange with 
D2O) ppm; 
13C NMR (100 MHz, DMSO-d6): δ 46.50 (CH2Ph), 115.51 (thiazole-C5), 
123.36, 126.52, 126.62, 127.27, 128.53, 128.87, 129.55, 129.96, 130.83 (Ar-CH), 131.80, 
135.35, 136.47, 138.64, 142.10 (Ar-C), 145.30 (thiazole-C4), 162.50 (thiazole-C2) ppm; 
IR (KBr)  = 3117 (hydrazo-NH), 3058, 3027 (Ar-CH), 2944 (Ali-CH), 1616 (C=N), 1587 
and 1491 cm-1 (Ar-C=C); MS (70 eV): m/z (%) = 447 (M+, 100), 371 (51), 265 (33), 189 
(73), 183 (40), 167 (83), 123 (32); Anal. Calcd for C22H17N5O4S (447.47): C 59.05, H 
3.83, N 15.65, S 7.17; Found: C 58.98, H 3.76, N 15.48, S 7.03. 
 
2.2.4. Synthesis of substituted thiazolium bromide dihydrate 19a-g. 
ω-Bromoacetophenone 2a/b (1.0 mmol, 2a, 0.198; 2b, 0.277 g) and substituted 
thiosemicarbazides 1a-d (l.0 mmol, 1a, 0.167; 1 b, 0.201; 1 c, 0.257 and 1d, 0.245 g) in 
30 ml absolute ethanol were stirred under reflux for 8-12 h. The reaction was follow up by 
TLC analysis. A precipitate from the salt 19a-g was formed (Scheme 6), filtered, washed 
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with a little of ethanol, dried and recrystallized from the mentioned solvent. 
2.2.4.1. 2-Amino-5-(4-aminophenyl)-4-phenylthiazol-3-ium bromide dihydrate 
(19a)  
Colorless crystals (ethanol); yield 426 mg (88%); Mp. 215-217°C; 1H NMR (400 MHz, 
CDCl3): δ 6.43-6.52 (br, s, 2H, NH2), 6.68-6.74 (br, s, 2H, thiazole-NH2), 7.05-7.10 (m, 
2H, Ar-H), 7.18-7.32 (m, 4H, Ar-H), 7.47-7.52 (m, 3H, Ar-H) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 115.09, 122.37, 128.12, 128.79, 130.61 (Ar-CH), 123.24, 127.24 (Ar-C), 
135.37 (thiazole-C4), 144.33 (Ar-C-NH2), 149.84 (thiazole-C5), 168.51 (thiazole-C2) 
ppm; IR (KBr): ν = 3325-3343 (NH2`s), 1607 (C=N), 1592 cm
-1 (Ar-C=C) ppm; MS (70 
eV): m/z (%) = 387/385 (M+, 15), 365 (M+ - HBr, 23), 267 (M+ - (HBr + H2O), 100), 190 
(16), 176 (33), 92 (19), 81 (38); Anal. Calcd for C15H18BrN3O2S (384.29): C 46.88, H 
4.72, Br 20.79, N 10.93, S 8.34; Found: C 46.97, H 4.83, Br 20.66, N 11.09, S 8.19. 
2.2.4.2. 2-Amino-5-(4-amino-2-chlorophenyl)-4-phenylthiazol-3-ium bromide 
dehydrate (19b)  
Colorless crystals (ethanol); yield 334 mg (80%); Mp. 210-212 °C; 1H NMR (400 MHz, 
DMSO-d6): δ = 6.53-6.58 (br, s, 2H, NH2), 6.72-6.76 (br, s, 2H, thiazole-NH2), 7.05-7.10 
(m, 2H, Ar-H), 7.23-7.49 (m, 6H, Ar-H) ppm; 13C NMR (100 MHz, DMSO-d6): δ = 
113.49, 116.02, 125.60, 127.73, 128.61, 129.08 (Ar-CH), 129.41, 131.43, 133.65 (Ar-C), 
134.26 (thiazole-C4), 143.89 (Ar-C-NH2), 150.35 (thiazole-C5), 168.08 (thiazole-C2) 
ppm; IR (KBr): ν = 3298-3275 (NH2`s), 1610 (C=N), 1588 cm
-1 (Ar-C=C); MS (70 eV): 
m/z (%) = 423/419 (M+, 8), 337 (M+ - HBr, 25), 302 (M+ - (HBr + H2O), 100), 225 (10), 
127(9), 81 (31); Anal. Calcd for C15H17BrClN3O2S (418.74): C 43.02, H 4.09, Br 19.08, 
Cl 8.47, N 10.03, S 7.66; Found: C 42.89, H 4.16, Br 18.96, Cl 8.58, N 9.91, S 7.59. 
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2.2.4.3. 2-Amino-5-(2-methyl-5-sulfamoylphenyl)-4-phenylthiazol-3-ium bromide 
dihydrate (19c)  
Colorless crystals (ethanol); yield 379 mg (82%); Mp. 232-234°C; 1H NMR (400 MHz, 
CDCl3): δ = 2.23 (s, 3H, CH3), 6.72-6.80 (br, s, 2H, thiazole-NH2), 7.09-7.15 (m, 2H, Ar-
H), 7.22-7.30 (m, 4H, Ar-H), 7.42-7.50 (br, s, 2H, SO2NH2),[29,30] 7.65-7.75 (m, 2H, Ar-
H) ppm; 13C NMR (100 MHz, CDCl3): δ = 29.27 (CH3); 123.36, 125.50, 127.47, 128.61, 
129.55, 129.94 (Ar-CH), 133.13, 133.37 (Ar-C), 134.08 (thiazole-C4), 136.44 (Ar-C-
SO2NH2), 144.82 (Ar-C-CH3); 150.62 (thiazole-C5), 169.20 (thiazole-C2) ppm; IR (KBr, 
cm-1): ν = 3332-3312 (NH2`s), 1625 (C=N), 1585 (Ar-C=C); MS (70 eV): m/z (%) = 
465/463 (M+, 7), 346 (M+ - (HBr + H2O), 100), 175 (24), 171 (21), 157 (26), 91 (42), 81 
(17); Anal. Calcd for C16H20BrN3O4S2 (462.38): C 41.56, H 4.36, Br 17.28, N 9.09, S 
13.87; Found: C 41.38, H 4.45, Br 17.19, N 8.88, S 14.04. 
2.2.4.4. 2-Amino-5-(2-amino-3,5-dinitrophenyl)-4-phenylthiazol-3-ium bromide 
dihydrate (19d)  
Brown crystals (ethanol); yield 403 mg (85%); Mp. 245-247°C; 1H NMR (400 MHz, 
DMSO-d6): δ = 6.68-6.76 (br, s, 2H, thiazole-NH2), 7.10-7.15 (br, s, 2H, NH2), 7.40-7.65 
(m, 3H, Ar-H), 8.10-8.18 (m, 2H, Ar-H), 8.60-8.70 (d, 1H, Ar-H), 8.96-9.10 (d, 1H, Ar-H) 
ppm; 13C NMR (100 MHz, DMSO-d6): δ = 120.43, 121.27, 126.04, 128.76, 129.06 (Ar-
CH); 123.37, 127.84 (Ar-C), 135.74 (thiazole-C4), 145.79 (Ar-C-NH2), 146.68, 148.63 
(Ar-C-NO2), 150.62 (thiazole-C5), 169.59 (thiazole-C2) ppm; IR (KBr): ν = 3332-3312 
(NH2`s), 1625 (C=N), 1585 cm
-1 (Ar-C=C); MS (70 eV): m/z (%) = 477/475 (M+, 12), 396 
(M+ - HBr, 26), 358 (M+ - (HBr + H2O), 100), 183 (24), 176 (22), 138 (69), 81 (17); Anal. 
Calcd for C15H16BrN5O6S (474.29): C 37.99, H 3.40, Br 16.85, N 14.77, S 6.76; Found: C 
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38.12, H 3.49, Br 16.73, N 14.64, S 6.94. 
2.2.4.5. 2-Amino-5-(4-aminophenyl)-4-(4-bromophenyl)-thiazol-3-ium bromide 
dihydrate (19e)  
Colorless crystals (ethanol); yield 426 mg (88%); Mp. 228-230°C; 1H NMR (400 MHz, 
CDCl3): δ = 6.44-6.56 (br, s, 2H, NH2), 6.66-6.74 (br, s, 2H, thiazole-NH2), 7.12-7.17 (m, 
2H, Ar-H), 7.20-7.30 (m, 4H, Ar-H), 7.38-7.46 (m, 2H, Ar-H) ppm; 13C NMR (100 MHz, 
CDCl3): δ = 116.32, 123.44, 128.35, 132.22 (Ar-CH), 123.13, 124.57, 133.78 (Ar-C), 
136.33 (thiazole-C4), 143.83 (Ar-C-NH2), 149.73 (thiazole-C5), 168.30 (thiazole-C2) 
ppm; IR (KBr): ν = 3310-3243 (NH2`s), 1623 (C=N), 1586 cm
-1 (Ar-C=C); MS (70 eV): 
m/z (%) = 467/463 (M+, 18), 381 (M+ - HBr, 23), 346 (M+ - (HBr + H2O), 100), 225 (20), 
191 (46), 92 (57), 81 (31); Anal. Calcd for C15H17Br2N3O2S (463.19): C 38.90, H 3.70, Br 
34.50, N 9.07, S 6.92; Found: C 39.04, H 3.61, Br 34.66, N 8.89, S 7.09. 
2.2.4.6. 2-Amino-4-(4-bromophenyl)-5-(2-methyl-5-sulfamoylphenyl) thiazol-3-ium 
bromide dihydrate (19f)  
Colorless crystals (ethanol); yield 433 mg (80%); Mp. 241-243°C; 1H NMR (400 MHz, 
CDCl3): δ = 2.27 (s, 3H, CH3), 6.60-6.72 (br, s, 2H, thiazole-NH2), 7.00-7.15 (m, 2H, Ar-
H), 7.32-7.38 (m, 3H, Ar-H), 7.45-7.52 (br, s, 2H, SO2-NH2),[30,31] 7.72-7.78 (m, 2H, 
Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δ = 29.72 (CH3), 127.35, 128.52, 129.90, 
130.09, 131.72 (Ar-CH), 124.63, 128.26, 135.50 (Ar-C), 134.82 (thiazole-C4), 136.28 
(Ar-C-SO2NH2), 145.30 (Ar-C-CH3), 150.43 (thiazole-C5), 170.18 (thiazole-C2) ppm; IR 
(KBr): ν = 3332-3312 (NH2`s), 1625 (C=N), 1585 cm
-1 (Ar-C=C); MS (70 eV): m/z (%) = 
545/541 (M+, 39), 460 (M+ - HBr, 20), 426 (M+ - (HBr + H2O), 100), 255 (34), 171 (68), 
157 (36), 91 (92); Anal. Calcd for C16H19Br2N3O4S2 (541.28): C 35.50, H 3.54, Br 29.52, 
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N 7.76, S 11.85; Found: C 35.39, H 3.62, Br 29.43, N 7.64, S 11.69. 
2.2.4.7. 2-Amino-5-(2-amino-3,5-dinitrophenyl)-4-(4-bromophenyl)thiazol-3-ium 
bromide dihydrate (19g)  
Brown crystals (ethanol); yield 459 mg (83%); Mp. 256-258°C; 1H NMR (400 MHz, 
DMSO-d6): δ = 6.78-6.83 (br, s, 2H, thiazole-NH2), 7.00-7.08 (br, s, 2H, NH2), 7.28-7.40 
(m, 4H, Ar-H), 8.23-8.65 (d, 1H, Ar-H), 8.82-8.98 (d, 1H, Ar-H) ppm; 13C NMR (100 
MHz, DMSO-d6) δ: 122.70, 129.47, 130.47, 131.59 (Ar-CH), 123.21, 125.81 (Ar-C), 
135.75 (thiazole-C4), 145.60 (Ar-C-NH2), 147.67, 148.70 (Ar-C-NO2), 150.00 (thiazole-
C5), 168.00 (thiazole-C2); IR (KBr): ν = 3332-3312 (NH2`s), 1625 (C=N), 1585 cm-1 (Ar-
C=C); MS (70 eV): m/z (%) = 557/553 (M+, 32), 472 (M+ - HBr, 34), 436 (M+ - (HBr + 
H2O), 100), 183 (51), 176 (22), 168 (26); Anal. Calcd for C15H15Br2N5O6S (553.18): C 
32.57, H 2.73, Br 28.89, N 12.66, S 5.80; Found: C 32.71, H 2.64, Br 29.03, N 12.76, S 
5.69. 
2.3. Single crystal X-ray structure determination of 3a, 16h and 19b 
The single crystal X-ray diffraction studies for 3a, 16h and 19b were carried out on a 
Bruker D8 Venture diffractometer with Photon 100 detector at 123 K using CuKα 
radiation (λ = 1.54178 Å) for 3a and 19b or MoKα radiation (λ = 0.71073 Å) for 16h. 
Direct methods (SHELXS-97)[31] were used for structure solution and refinement was 
carried out using SHELXS-2013/2014[32] (full-matrix least squares on F2). Hydrogen 
atoms were localized by difference Fourier synthesis map and refined using a riding model 
[H(N, O) free]. Semi-empirical absorption corrections were applied. For 16h and 19b 
extinction correction was applied. The absolute structure of 19b is determined by 
refinement of Parsons Flack parameter.[33] 
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2.3.1. Compound 3a: C15H11N3S, Mr = 265.33 g mol-1, orange blocks, crystal size = 0.22 
x 0.10 x 0.05 mm, monoclinic space group P21/c (no. 14), a = 21.7180(5) Å, b = 5.1347(1) 
Å, c = 11.3211(3) Å, β = 92.280 (1)o, V = 1261.48(5) Å3, Z = 4, Dcalcd = 1.397 Mg m
-3, 
F(000) = 552, μ = 2.170 mm-1, T =123 K, 14789 measured reflections (2θmax = 144.0
o), 
2473 independent reflections [Rint = 0.027], 172 parameters, R1[for 2305 with I>2σ(I)] = 
0.028, wR2 (for all data) = 0.073, S = 1.04, largest diff. peak and hole = 0.327 e Å
-3 /-
0.184 e Å-3.  
2.3.2. Compound 16h: C23H21N3O2S2, Mr = 435.55 g mol-1, violet blocks, crystal size = 
0.45 x 0.35 x 0.20 mm, monoclinic space group P21/c (no. 14), a = 9.3897(5) Å, b = 
11.0215(5) Å, c = 20.0638(9) Å, β = 101.146 (2)o, V = 2037.21(17) Å3, Z = 4, Dcalcd = 
1.420 Mg m-3, F(000) = 912, μ = 0.288 mm-1, T = 123 K, 59879 measured reflections 
(2θmax = 55.0
o), 4684 independent reflections [Rint = 0.033], 276 parameters, 1 restraint, R1 
[for 4231 with I>2σ(I)] = 0.032, wR2 [for all data] = 0.079, S = 1.07, largest diff. peak and 
hole = 0.499 e Å-3 /-0.431 e Å-3. 
2.3.3. Compound 19b: C15H13ClN3S∙Br∙2(H2O), Mr = 418.74 g mol-1, colorless blocks, 
crystal size = 0.25 x 0.20 x 0.10 mm, orthorhombic space group P212121 (no. 19), a = 
7.2127(2) Å, b = 10.7593(3) Å, c = 21.8730(5) Å, V = 1697.42(8) Å3, Z = 4, Dcalcd = 1.639 
Mg m-3, F(000) = 848, μ = 6.008 mm-1, T = 123 K, 17133 measured reflections (2θmax = 
144.2o), 3324 independent reflections [Rint = 0.027], 236 parameters, R1[for 3291with 
I>2σ(I)], wR2[for all data] = 0.045, S = 1.08, largest diff. peak and hole = 0.382 e Å
-3 /-





3. Results and Discussion 
In our present studies arylthiosemicarbazides 1a-d and ω-bromoacetophenones 2a,b were 
selected as reagents under Eschenmoser-contraction method [34,35] (Scheme 1 and 2) to 
receive a new C-C bond and synthesize aminophenylpyrazoles 14 (Scheme 3) instead,  4-
aryl (2-alkyldiazenylthiazole) 3a-e were observed (Scheme 1). 
(Scheme 1) 
The mechanism for the formation of 3a-e is illustrated in scheme 2. Upon adding different 
amounts of triphenylphosphine as a thiophile and triethylamine as the base, the reaction 
does not produce a significant change in the products 3a-e, and the yields were roughly the 
same. Also, it was found that Et3N plays an important role on the reaction efficiency and 
products 3a-e, even in the absence of thiophile Ph3P (Scheme 2 and Scheme 3). 
(Scheme 2) 
 (Scheme 3) 
The present study will discuss the behavior of ω-bromoacetophenones 2a,b towards 1,4-
disubstituted thiosemicarbazides 15a-e and will be compared to the behavior of the same 
compounds towards 1a-d. Hydrazinothiazoles 16a-i was formed during the reaction of 
2a,b with 15a-e (Scheme 4). 
(Scheme 4) 
The mechanism for the formation of the compounds 16a-i is shown in scheme 5. 
(Scheme 5) 
In the present study, condensation of ω-bromoacetophenones 2a,b with substituted 
thiosemicarbazides 1a-d afforded 2-amino-5-(4-aminophenyl)-4-phenyl-thiazol-3-ium 




The mechanism for the formation of 19a-g is described in Scheme 7, whereas, the 
mechanism for the formation of 19c,f is described in Scheme 8. 
(Scheme 7) 
(Scheme 8) 
All the synthesized compounds have been characterized by means of both analytical and 
spectroscopic methods, as follows. 
3.1. Infrared spectroscopy of 3a-e, 16a-I and 19a-g. 
 
Figure 1 
All compounds 3a-e exhibit orange colors: The IR spectrum of 3a (Fig. 1 as an example of 
diazenylthiazoles) showed characteristic bands of aromatic groups were observed at 1585 
cm-1 corresponding to Ar-C=C stretching vibration of benzene and thiazole rings. The 
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C=N stretching band at 1600 cm-1. The IR spectrum of 3a confirm the presence of azo 
group (N=N) at 1560 and 1444 cm-1.  
In the hydrazothiazoles 16a-i the IR peaks showed at 3263-3193 cm-1 broad bands of 
hydrazo-NH group, C=N at 1626-1611 cm-1. 
The IR spectrum of 19b showed bands at 3298-3275 cm-1 due to NH2 groups and bands at 
1610 (C=N), 1588 cm-1 (Ar-C=C).  
3.2. 1H and 13C NMR spectra of 3a-e, 16a-i and 19a-g. 
 
Figure 2 
The NMR spectra (1Hand 13C) of compound 3a were recorded using CDCl3 as solvent and 
TMS as an internal standard (Figure 2) which showed three multiplets corresponding to 
ten protons at δ = 7.40-7.58 and 8.03-8.88 ppm due to aryl protons.  
The 13C NMR of 3a (Figure 3) contained three signals at δ = 168.46 (thiazole-C2), 155.85 
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(thiazole-C4) and 115.88 ppm (thiazole-CH), with the absence of C=S group. The 
downfield shift of thiazole-C2,4 is due to the high conjugation of thiazole ring with respect 
to azo- and aryl groups. From the spectral data, it can be concluded that 1NH, 3NH,4NH 
and thioxo group are the nucleophilic sites to form the products 3a-e. 
 
Figure 3 
The 1H NMR spectrum of 16b showed one broad signal at δ = 10.53 ppm due to hydrazo-
NH which was confirmed further by H2O exchange experiment. Also, the aromatic 
protons observed in the expected region 7.48-7.52, 8.28-8.38 and 8.87-8.89 ppm. One 
singlet at δ = 6.91 because of thiazole-CH. Signals at 1.06-1.09, 1.76-1.78 and 3.72-3.74 
due to cyclohexyl-CH2 and CH.  
In the 13C NMR spectra of 16b signals at δ = 164.40, 144.90 and 115.45 ppm were 
assigned to thiazole-C2, thiazole-C4 and thiazole-CH, respectively. 
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On the other hand, in the 1H NMR spectrum of 19b, two broad signals at 6.53-6.58 and 
6.72-6.76 ppm are due to NH2 attached to phenyl ring and the other for NH2 attached to 
thiazole ring. Eight protons were observed at δ = 7.05-7.10 and 7.23-7.49 ppm because of 
aromatic protons.  
The 13C NMR spectra of 19b showed downfield shifted signals at 168.08 (thiazole-C2) 
and 150.35 (thiazole-C5). Signals at 129.41, 131.43 and 133.65 (Ar-C), 143.89 (Ar-C-
NH2), 134.26 (thiazole-C4), in addition to the signals of Ar- CH. 
3.3. Mass spectrometry of 3a-e, 16a-I and 19a-g. 
Elemental analyses and mass spectra of compounds 3a-e clearly showed that the 
azothiazoles 3a-e were formed during the addition equimolar amounts of 
thiosemicarbazides 1a-d and acetophenones 2a,b via elimination (HBr + H2O). 
Form the mass spectrometry of 16b, the molecular ion peak at m/z = 439 (16%) with 
abstraction HBr and H2O from the reactants. 
The molecular ion peak of 19b as an example of thiazolium bromide dihydrates at m/z = 
423/419 (M+, 9%) with molecular formula C15H17BrClN3O2S and fragmentation patterns 
at 337 (M+ - HBr, 25), 302 (M+ - (HBr + H2O), 100). 
3.4. X-ray structure determination of 3a, 16h and 19b. 
Suitable single crystals for X-ray analysis of compound 3a were obtained by 
crystallization from acetonitrile. X-ray crystallography (Fig. 6, Tables S1-S6 in the 
supporting information) provided unambiguous proof that (E)-4-phenyl-2- 
(phenyldiazenyl)thiazole 3a was formed exclusively during the reaction of 1a with 2a. The 
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X-ray analysis of 3a confirms a transiod geometry with respect to the N7-N8 double bond. 




For the hydrazonothiazoles 16a-i, the overall structure including the Z-configuration was 
also confirmed by X-ray crystallography of one derivative 16h (Figure 5, Tables S7-S13). 
 
Figure 5 
The molecular structure of 5-(4-amino-2-chlorophenyl)-4-phenylthiazol-2(3H)-iminium 






The dihedral angle between S1/N3-C2-C5 thiazole and C6-C11 in phenyl rings is 75.0°. In 




Novel diazenylthiazoles, hydrazothiazoles and substituted thiazolium bromide dihydrates 
have been synthesized from the nucleophilic addition followed by condensation between 
mono or disubstituted thiosemicarbazides and ω-bromoacetophenones.   
Appendix A. Supplementary data 
Crystallographic data (excluding structure factors) for the structure reported in this work 
have been deposited with Cambridge Crystallographic Data Center as supplementary 
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publication no CCDC 1583184 (3a), 1589939 (16h) and 1583185 (19b) contain the 
supplementary crystallographic data for this paper [36]. These data can be obtained free of 
charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif 
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Figure 1: FT-IR Spectrum of compound 3a. 
Figure 2: 1H NMR of (E)-4-Phenyl-2-(phenyldiazenyl)thiazole (3a) obtained in CDCl3. 
Figure 3: 13C NMR of (E)-4-Phenyl-2-(phenyldiazenyl)thiazole (3a) obtained in CDCl3. 
Figure 4: The X-ray structure of compound 3a in crystal (displacement parameters are 
drawn at 50% probability level). 
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Figure 5: The overall structure including the Z-configuration was also confirmed by X-ray 
crystallography of one derivative 16h displacement parameters are drawn at 50% 
probability level). 
Figure 6: The hydrogen bonds formed via the bromide ion as well as H2O molecules in 

































Scheme 3: The unreactivity of 1a-d and 2a,b towards Eschenmoser-contraction and 
formation of pyrazoles 14.  
 
 
Scheme 4: Synthesis of hydrazinothiazoles 16a-i. 
 












Scheme 8: Mechanistic considerations for the formation of compounds 19c,f. 
 
Highlights: 
 Eschenmoser-coupling reaction and synthesis of diazenylthiazoles. 
 Synthesis of hydrazothiazoles. 
 Synthesis of thiazolium bromide dihydrate derivatives via [5.5] sigmatropic shift. 
 Crystallographic behavior of the title compounds. 
 Lattice water and bromide ion associated through hydrogen bonded with thiazole-
NH2 in thiazolium bromide. 
 
 
